On Friday, 21 November 2025, Eli Lilly became the first pharmaceutical company to reach a valuation typically reserved for major technology giants: USD 1 trillion. The milestone was achieved when its share price hit $1,057.78. Alongside Big Tech, the company now trades at valuations that—while elevated, as we will see shortly—many analysts consider justified by […]